Brazil’s federal health regulator Anvisa on Saturday suspended the use of over 12 million doses of a COVID-19 vaccine developed by China’s Sinovac Biotech Ltd that were produced in an unauthorized plant, it said in a statement. Anvisa said it was alerted on Friday by Sao Paulo’s Butantan institute, a biomedical center that has partnered […]